Global Direct-to-Consumer (DTC)Testing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Direct-to-Consumer (DTC)Testing Market Research Report 2024
With advances in technology, the completion of the sequencing of the human genome and the pressures of capitalism, direct to consumer (DTC) laboratory testing is becoming increasingly popular. The growing market for DTC laboratory testing may promote awareness of health issues and genetic diseases, which could allow patients to take a more proactive role in their healthcare.
According to Mr Accuracy reports’s new survey, global Direct-to-Consumer (DTC)Testing market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Direct-to-Consumer (DTC)Testing market research.
Key companies engaged in the Direct-to-Consumer (DTC)Testing industry include 23andMe, deCODEme, DNA DTC, GeneByGene, Genecodebook Oy, Genetrainer, MD Revolution, Myriad Genetics and Navigenics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Direct-to-Consumer (DTC)Testing were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Direct-to-Consumer (DTC)Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Direct-to-Consumer (DTC)Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
23andMe
deCODEme
DNA DTC
GeneByGene
Genecodebook Oy
Genetrainer
MD Revolution
Myriad Genetics
Navigenics
Segment by Type
Routine Clinical Laboratory Testing
Medical Genetic Laboratory Testing
Doctor Office
Internet
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Direct-to-Consumer (DTC)Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Direct-to-Consumer (DTC)Testing market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Direct-to-Consumer (DTC)Testing market research.
Key companies engaged in the Direct-to-Consumer (DTC)Testing industry include 23andMe, deCODEme, DNA DTC, GeneByGene, Genecodebook Oy, Genetrainer, MD Revolution, Myriad Genetics and Navigenics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Direct-to-Consumer (DTC)Testing were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Direct-to-Consumer (DTC)Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Direct-to-Consumer (DTC)Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
23andMe
deCODEme
DNA DTC
GeneByGene
Genecodebook Oy
Genetrainer
MD Revolution
Myriad Genetics
Navigenics
Segment by Type
Routine Clinical Laboratory Testing
Medical Genetic Laboratory Testing
Segment by Application
Doctor Office
Internet
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Direct-to-Consumer (DTC)Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source